Form 4 Tracker
Martine A Rothblatt

Director; Director, Chairperson & CEO · 165 filings · Latest: Oct 15, 2026

BETA Technologies, Inc.
UNITED THERAPEUTICS Corp
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 20, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 19, 2026
Sale
$528.839,500$5.0M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 19, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 18, 2026
Sale
$529.599,500$5.0M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 18, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 17, 2026
Sale
$536.759,500$5.1M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 17, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 16, 2026
Sale
$533.909,500$5.1M40,513
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 16, 2026
Option Exercise
$146.039,500$1.4M50,013
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 15, 2026
Option Exercise
—69,579—69,709
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 13, 2026
Sale
$538.009,500$5.1M130
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 13, 2026
Option Exercise
$146.039,500$1.4M9,630
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 16, 2026
Sale
$534.99516$276.1K8,414
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 12, 2026
Sale
$537.978,984$4.8M130
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 12, 2026
Option Exercise
$146.039,500$1.4M9,630
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 11, 2026
Sale
$539.549,500$5.1M130
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 11, 2026
Option Exercise
$146.039,500$1.4M9,630
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 10, 2026
Sale
$539.719,500$5.1M130
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 10, 2026
Option Exercise
$146.039,500$1.4M9,630
UTHR
Martine A RothblattDirector, Chairperson & CEOMar 9, 2026
Sale
$518.039,500$4.9M130